Thomas Vauvert F Hviid Selected Research

HLA-G Antigens (HLA G)

1/2022	An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer.
1/2022	HLA Class Ib-receptor interactions during embryo implantation and early pregnancy.
11/2021	Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters.
10/2021	Evidence for a shift in placental HLA-G allelic dominance and the HLA-G isoform profile during a healthy pregnancy and preeclampsia†.
4/2020	A role for both HLA-F and HLA-G in reproduction and during pregnancy?
1/2020	Examining extended human leukocyte antigen-G and HLA-F haplotypes: the HLA-G UTR-4 haplotype is associated with shorter time to pregnancy in an infertility treatment setting when both female and male partners are carriers.
9/2018	Implications of uterine NK cells and regulatory T cells in the endometrium of infertile women.
7/2018	Extended HLA-G haplotypes in patients with age-related macular degeneration.
1/2018	The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G.
10/2017	HLA class Ia and Ib molecules and FOXP3+ TILs in relation to the prognosis of malignant melanoma patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Vauvert F Hviid Research Topics

Disease

12	Pre-Eclampsia (Preeclampsia) 10/2021 - 04/2004
8	Pregnancy Complications 01/2022 - 05/2006
7	Infertility (Sterility) 01/2022 - 01/2012
7	Spontaneous Abortion (Miscarriage) 01/2020 - 05/2003
6	Neoplasms (Cancer) 01/2022 - 03/2006
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 06/2005
2	Breast Neoplasms (Breast Cancer) 11/2021 - 11/2021
2	Hypersensitivity (Allergy) 01/2019 - 01/2013
2	Melanoma (Melanoma, Malignant) 10/2017 - 01/2016
2	Birth Weight (Birth Weights) 01/2017 - 01/2017
2	Habitual Abortion (Recurrent Miscarriage) 04/2015 - 01/2012
2	Sarcoidosis (Schaumann Disease) 12/2007 - 03/2006
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Female Infertility 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 07/2018
1	Choriocarcinoma 01/2018
1	Left Ventricular Dysfunction 01/2016
1	Hypertension (High Blood Pressure) 02/2014
1	Vascular Remodeling 01/2014
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2013
1	Prolapse 05/2010
1	Premature Birth (Birth, Premature) 11/2009
1	Chronic Granulomatous Disease 12/2007
1	Blau syndrome 12/2007
1	Crohn Disease (Crohn's Disease) 01/2007
1	Granuloma 03/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2006

Drug/Important Bio-Agent (IBA)

27	HLA-G Antigens (HLA G)IBA 01/2022 - 05/2003
8	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 06/2005
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2006
3	CytokinesIBA 11/2021 - 01/2013
3	AntigensIBA 01/2016 - 01/2006
2	Protein Isoforms (Isoforms)IBA 10/2021 - 11/2009
2	CaspasesIBA 12/2007 - 01/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	KIR ReceptorsIBA 01/2019
1	HLA-C Antigens (HLA-C)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2016
1	CreatinineIBA 02/2014
1	Lipocalin-2IBA 02/2014
1	3' Untranslated Regions (3' UTR)IBA 07/2013
1	Immunoglobulin E (IgE)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	AllergensIBA 01/2013
1	CollagenIBA 05/2010
1	NucleotidesIBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2007
1	Peptides (Polypeptides)IBA 01/2006

Therapy/Procedure

4	Organ Transplantation 07/2013 - 01/2006
2	Therapeutics 01/2019 - 01/2014
2	Immunotherapy 10/2017 - 01/2013
1	Transplantation 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Salpingectomy 09/2017
1	Immunomodulation 01/2013